Serine proteases degrade airway mucins in cystic fibrosis

Infection and Immunity

Volumn 79, Issue 8, 2011, Pages 3438-3444

  Henke, Markus O ^a   John, Gerrit ^a,b   Rheineck, Christina ^a   Chillappagari, Shashi ^a   Naehrlich, Lutz ^c   Rubin, Bruce K ^d  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; BENZYLSULFONYL FLUORIDE; DYFLOS; EDETIC ACID; ILOMASTAT; LEUKOCYTE ELASTASE; LEUPEPTIN; MUCIN 5AC; MUCIN 5B; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PSEUDOLYSIN; SERINE PROTEINASE; TOSYLLYSYL CHLOROMETHYL KETONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCINS; NEUTROPHILS; PANCREATIC ELASTASE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY SYSTEM; SERINE PROTEASES; YOUNG ADULT;

EID: 79961121946     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01252-10     Document Type: Article

References (49)

1. Alcorn, J. F., and J. R. Wright. 2004. Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J. Biol. Chem. 279:30871-30879. doi:10.1074/jbc.M400796200.
2. Antonicelli, F., G. Bellon, L. Debelle, and W. Hornebeck. 2007. Elastinelastases and inflamm-aging. Curr. Top. Dev. Biol. 79:99-155.
3. Aristoteli, L. P., and M. D. Willcox. 2003. Mucin degradation mechanisms by distinct Pseudomonas aeruginosa isolates in vitro. Infect. Immun. 71:5565-5575.
4. Barasch, J., et al. 1991. Defective acidification of intracellular organelles in cystic fibrosis. Nature 352:70-73.
5. Belaaouaj, A., et al. 1998. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4:615-618.
6. Birrer, P. 1995. Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies. Respiration 62(Suppl. 1):25-28.
7. Birrer, P., et al. 1994. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150:207-213.
8. Boat, T. F., and P. W. Cheng. 1980. Biochemistry of airway mucus secretions. Fed. Proc. 39:3067-3074.
9. Carnoy, C., et al. 1993. Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa. Am. J. Respir. Cell Mol. Biol. 9:323-334.
10. Chapman, H. A., Jr., and G. P. Shi. 2000. Protease injury in the development of COPD: Thomas A. Neff Lecture. Chest 117:295S-299S.
11. Cone, R. A. 2009. Barrier properties of mucus. Adv. Drug Deliv. Rev. 61: 75-85. doi:10.1016/j.addr.2008.09.008.
12. Denton, R., W. Forsman, S. H. Hwang, M. Litt, and C. E. Miller. 1968. Viscoelasticity of mucus. Its role in ciliary transport of pulmonary secretions. Am. Rev. Respir. Dis. 98:380-391.
13. Esterly, J. R., and E. H. Oppenheimer. 1968. Cystic fibrosis of the pancreas: structural changes in peripheral airways. Thorax 23:670-675.
14. Finkelstein, R. A., M. Boesman-Finkelstein, and P. Holt. 1983. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc. Natl. Acad. Sci. U. S. A. 80:1092-1095.
15. Garcia-Verdugo, I., D. Descamps, M. Chignard, L. Touqui, and J. M. Sallenave. 2010. Lung protease/anti-protease network and modulation of mucus production and surfactant activity. Biochimie 92:1608-1617.
16. Ginzberg, H. H., et al. 2001. Neutrophil-mediated epithelial injury during transmigration: role of elastase. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G705-G717.
17. Goldstein, W., and G. Doring. 1986. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134:49-56.
18. Hase, C. C., and R. A. Finkelstein. 1990. Comparison of the Vibrio cholerae hemagglutinin/protease and the Pseudomonas aeruginosa elastase. Infect. Immun. 58:4011-4015.
19. Henke, M. O., G. John, M. Germann, H. Lindemann, and B. K. Rubin. 2007. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Am. J. Respir. Crit. Care Med. 175:816-821.
20. Henke, M. O., A. Renner, R. M. Huber, M. C. Seeds, and B. K. Rubin. 2004. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am. J. Respir. Cell Mol. Biol. 31:86-89.
21. Hovenberg, H. W., J. R. Davies, and I. Carlstedt. 1996. Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem. J. 318(Pt. 1):319-324.
22. Kim, J. S., G. H. Hackley, K. Okamoto, and B. K. Rubin. 2001. Sputum processing for evaluation of inflammatory mediators. Pediatr. Pulmonol. 32:152-158.
23. Kim, K. C., et al. 1987. Human neutrophil elastase releases cell surface mucins from primary cultures of hamster tracheal epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 84:9304-9308.
24. Kirkham, S., J. K. Sheehan, D. Knight, P. S. Richardson, and D. J. Thornton. 2002. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem. J. 361:537-546.
25. Klinger, J. D., B. Tandler, C. M. Liedtke, and T. F. Boat. 1984. Proteinases of Pseudomonas aeruginosa evoke mucin release by tracheal epithelium. J. Clin. Invest. 74:1669-1678.
26. Kohri, K., I. F. Ueki, and J. A. Nadel. 2002. Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am. J. Physiol. Lung Cell Mol. Physiol. 283:L531-L540.
27. Lemjabbar, H., and C. Basbaum. 2002. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat. Med. 8:41-46.
28. Miyoshi, S., and S. Shinoda. 2000. Microbial metalloproteases and pathogenesis. Microbes. Infect. 2:91-98. doi:10.1016/S128645790000280X.
29. Nadel, J. A. 1991. Role of mast cell and neutrophil proteases in airway secretion. Am. Rev. Respir. Dis. 144:S48-S51.
30. Noah, T. L., H. R. Black, P. W. Cheng, R. E. Wood, and M. W. Leigh. 1997. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J. Infect. Dis. 175:638-647.
31. Picot, R., I. Das, and L. Reid. 1978. Pus, DNA, and sputum viscosity. Thorax 33:235-242.
32. Puchelle, E., S. de Bentzmann, and J. M. Zahm. 1995. Physical and functional properties of airway secretions in cystic fibrosis-therapeutic approaches. Respiration 62(Suppl. 1):2-12.
33. Quinton, P. M. 2008. Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet 372:415-417.
34. Ratjen, F., C. M. Hartog, K. Paul, J. Wermelt, and J. Braun. 2002. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax 57:930-934.
35. Rees, D. D., J. D. Brain, M. E. Wohl, J. L. Humes, and R. A. Mumford. 1997. Inhibition of neutrophil elastase in CF sputum by L-658,758. J. Pharmacol. Exp. Ther. 283:1201-1206.
36. Rose, M. C., and J. A. Voynow. 2006. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 86:245-278.
37. Rubin, B. K., B. Finegan, O. Ramirez, and M. King. 1990. General anesthesia does not alter the viscoelastic or transport properties of human respiratory mucus. Chest 98:101-104.
38. Rubin, B. K., and M. King. 1996. Mucus physiology and pathophysiology: therapeutic aspects, p. 391-411. In J. P. Derenne, T. Similowski, and W. A. Whitelaw (ed.), Acute respiratory failure in chronic obstructive lung disease. Marcel Dekker, New York, NY.
39. Rubin, B. K., O. Ramirez, J. G. Zayas, B. Finegan, and M. King. 1990. Collection and analysis of respiratory mucus from subjects without lung disease. Am. Rev. Respir. Dis. 141:1040-1043.
40. Sheehan, J. K., et al. 2004. Identification of molecular intermediates in the assembly pathway of the MUC5AC mucin. J. Biol. Chem. 279:15698-15705.
41. Smith, L., et al. 2006. Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. J. Med. Microbiol. 55:1641-1644.
42. Suzuki, T., et al. 2005. Proteinase-activated receptor-1 mediates elastaseinduced apoptosis of human lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 33:231-247.
43. Thornton, D. J., et al. 1996. Respiratory mucins: identification of core proteins and glycoforms. Biochem. J. 316(Pt. 3):967-975.
44. Voynow, J. A., B. M. Fischer, and S. Zheng. 2008. Proteases and cystic fibrosis. Int. J. Biochem. Cell Biol. 40:1238-1245.
45. Voynow, J. A., and B. K. Rubin. 2009. Mucins, mucus, and sputum. Chest 135:505-512.
46. Voynow, J. A., et al. 1999. Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am. J. Physiol. 276: L835-L843.
47. Wickstrom, C., J. R. Davies, G. V. Eriksen, E. C. Veerman, and I. Carlstedt. 1998. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem. J. 334(Pt. 3):685-693.
48. Wolf, D. P., L. Blasco, M. A. Khan, and M. Litt. 1977. Human cervical mucus. I. Rheologic characteristics. Fertil. Steril. 28:41-46.
49. Wolters, P. J., and H. A. Chapman. 2000. Importance of lysosomal cysteine proteases in lung disease. Respir. Res. 1:170-177.